-

02:20:41 AM

CDNA Stock News

CDNA - Caredx Inc

03/16/22 7:00 AM

Nasdaq : CDNA

CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced

RHEA-AI

very positive

03/14/22 8:06 PM

Nasdaq : CDNA

CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the

RHEA-AI

very negative

03/03/22 7:00 AM

Nasdaq : CDNA

CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and

RHEA-AI

very positive

03/02/22 7:00 AM

Nasdaq : CDNA

partnership

CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and

RHEA-AI

neutral

02/24/22 4:01 PM

Nasdaq : CDNA

CareDx Reports Fourth Quarter and Full Year 2021 Results

RHEA-AI

neutral

02/22/22 7:00 AM

Nasdaq : CDNA

CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring World’s First Successful Living Xenotransplantation

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of

RHEA-AI

positive

02/17/22 4:01 PM

Nasdaq : CDNA

conferencesearnings

CareDx to Report Fourth Quarter and Full Year 2021 Financial Results

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report

RHEA-AI

neutral

02/14/22 7:00 AM

Nasdaq : CDNA

On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a Transplant

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery,

RHEA-AI

neutral

02/08/22 7:00 AM

Nasdaq : CDNA

CareDx Taps into Its Patient Network to Deliver Insights on Transplant Needs

CareDx, Inc. (Nasdaq: CDNA)

RHEA-AI

very positive

02/07/22 7:00 AM

Nasdaq : CDNA

conferences

CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host “Heart Health” Webinar for Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused

RHEA-AI

neutral

Prev 1 2 3 4 5 6 7 8 9 10 Next

CDNA Data

IndustryMedical Laboratories
Websitewww.caredx.com
CeoPeter Maag
Security nameCaredx Inc
Issue typecs
SectorHealth Care and Social Assistance
Sic code8071
Employees466
Tags
- Health Technology
- Medical Specialties
- Health Care and Social Assistance
- Medical Laboratories
Address1 Tower Place
Address29Th Floor
StateCalifornia
CitySouth San Francisco
Zip94080
CountryUS
Phone14152872300

About Caredx Inc

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.